📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Chestnut Medical

1.1 - Company Overview

Chestnut Medical Logo

Chestnut Medical

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of minimally invasive therapies and technologies for interventional neuroradiology, focused on improving outcomes and reducing complications in the treatment of neurovascular disease.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Chestnut Medical

4P-Pharma Logo

4P-Pharma

HQ: France Website
  • Description: Provider of clinical-stage regenerating active drugs and therapies for serious diseases, including 4P004, a GLP-1 analog for osteoarthritis; 4P022, an AI platform-based treatment for systemic sclerosis; 4P025 for primary sclerosing cholangitis; 4P021, a CXCR4 antagonist for acute respiratory distress syndrome and pulmonary complications; and 4P020, a beta-3 adrenergic receptor agonist for Stargardt disease and dry age-related macular degeneration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 4P-Pharma company profile →
Longeviti Neuro Solutions Logo

Longeviti Neuro Solutions

HQ: United States Website
  • Description: Provider of implantable neurosurgical devices, developing and commercializing these products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Longeviti Neuro Solutions company profile →
NKGen Biotech Logo

NKGen Biotech

HQ: United States Website
  • Description: Provider of natural killer (NK) cell therapy candidates to restore immune function for cancer treatment, including SNK01, an autologous NK therapy in clinical trials for neurodegenerative diseases and various cancers, and SNK02, an allogeneic NK therapy being tested for solid tumors, plus an Expanded Access Program enabling access to investigational therapies under specific conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NKGen Biotech company profile →
Avid Radiopharmaceuticals Logo

Avid Radiopharmaceuticals

HQ: United States Website
  • Description: Provider of molecular imaging agents to aid detection and monitoring of chronic human diseases. Products include FDA-approved PET imaging agents: Amyvid for detecting beta-amyloid plaques in the brain and Tauvid for detecting tau pathology in patients evaluated for Alzheimer's disease. Based in Philadelphia, PA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avid Radiopharmaceuticals company profile →
Avanir Pharmaceuticals Logo

Avanir Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines for central nervous system disorders, focused on high unmet medical need. Offers Nuedexta, a medication used to treat pseudobulbar affect (PBA), characterized by sudden, uncontrollable episodes of crying or laughing. Extensively invests in its pipeline and is dedicated to advancing medicines that can substantially improve patients' lives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avanir Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Chestnut Medical

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Chestnut Medical

2.2 - Growth funds investing in similar companies to Chestnut Medical

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Chestnut Medical

4.2 - Public trading comparable groups for Chestnut Medical

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Chestnut Medical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Chestnut Medical

What does Chestnut Medical do?

Chestnut Medical is a provider of minimally invasive therapies and technologies for interventional neuroradiology, focused on improving outcomes and reducing complications in the treatment of neurovascular disease.

Who are Chestnut Medical's competitors?

Chestnut Medical's competitors and similar companies include 4P-Pharma, Longeviti Neuro Solutions, NKGen Biotech, Avid Radiopharmaceuticals, and Avanir Pharmaceuticals.

Where is Chestnut Medical headquartered?

Chestnut Medical is headquartered in United States.

How many employees does Chestnut Medical have?

Chestnut Medical has 1,000 employees 🔒.

When was Chestnut Medical founded?

Chestnut Medical was founded in 2010 🔒.

What sector and industry vertical is Chestnut Medical in?

Chestnut Medical is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Chestnut Medical

Who are the top strategic acquirers in Chestnut Medical's sector and industry

Top strategic M&A buyers and acquirers in Chestnut Medical's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Chestnut Medical?

Top strategic M&A buyers groups and sectors for Chestnut Medical include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Chestnut Medical's sector and industry vertical

Which are the top PE firms investing in Chestnut Medical's sector and industry vertical?

Top PE firms investing in Chestnut Medical's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Chestnut Medical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Chestnut Medical's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Chestnut Medical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Chestnut Medical include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Chestnut Medical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Chestnut Medical?

The key public trading comparables and valuation benchmarks for Chestnut Medical include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Chestnut Medical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Chestnut Medical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Chestnut Medical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Chestnut Medical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Chestnut Medical's' sector and industry vertical?

Access recent funding rounds and capital raises in Chestnut Medical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Chestnut Medical